Form 8-K · Current report
IQVIA 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0001478242
- Accession no.
- 0001628280-26-067406
Summary
IQVIA reported third-quarter 2026 revenue of $4,428 million, up 8.0% year over year, and raised its full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted diluted EPS. CEO Ari Bousbib said the quarter exceeded the high end of expectations, citing favorable demand indicators, margin expansion, and higher clinical bookings.
Key points
- IQVIA reported third-quarter 2026 revenue of $4,428 million, up 8.0% year over year, GAAP net income of $350 million, and adjusted diluted EPS of $3.34.
- R&D Solutions net new bookings were $3.2 billion, up 15% year over year, with contracted backlog of $32.6 billion as of September 30, 2026.
- IQVIA raised its full-year 2026 guidance to revenue of $17,350–$17,500 million, adjusted EBITDA of $4,025–$4,055 million, and adjusted diluted EPS of $12.90–$13.00.
- CEO Ari Bousbib said the quarter exceeded the high end of expectations, citing favorable demand indicators, margin expansion, higher clinical bookings, and over 400 AI agents deployed.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On October 27, 2026, IQVIA Holdings Inc. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2026. The full text of the press release was posted on the Company’s internet website and is furnished as Exhibit 99.1 hereto and incorporated herein by reference. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information contained in, or incorporated into, Item 2.02, including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.